Quick Answer
NEOGENOMICS INC reported Operating Income Loss of -$115.88 million for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -25.8% in Operating Income Loss from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $42.0 thousand | Q1 2012: $861.0 thousand | Q2 2012: $839.0 thousand | Q3 2012: -$684.0 thousand | Q1 2013: $305.0 thousand | Q2 2013: $505.0 thousand | Q3 2013: $1.16 million | Q1 2014: $394.0 thousand | Q2 2014: $578.0 thousand | Q3 2014: -$73.0 thousand | Q1 2015: -$561.0 thousand | Q2 2015: $28.0 thousand | Q3 2015: $114.0 thousand | Q1 2016: $1.92 million | Q2 2016: $2.19 million | Q3 2016: $1.40 million | Q1 2017: -$580.0 thousand | Q2 2017: $1.84 million | Q3 2017: -$2.06 million | Q1 2018: $2.51 million | Q2 2018: $794.0 thousand | Q3 2018: $3.92 million | Q1 2019: $2.55 million | Q2 2019: $4.48 million | Q3 2019: $3.66 million | Q1 2020: -$5.29 million | Q2 2020: -$18.91 million | Q3 2020: $4.67 million | Q1 2021: -$15.11 million | Q2 2021: -$22.37 million | Q3 2021: -$39.71 million | Q1 2022: -$52.03 million | Q2 2022: -$39.70 million | Q3 2022: -$39.51 million | Q1 2023: -$35.07 million | Q2 2023: -$29.89 million | Q3 2023: -$24.20 million | Q1 2024: -$30.57 million | Q2 2024: -$21.94 million | Q3 2024: -$21.20 million | Q1 2025: -$27.83 million | Q2 2025: -$47.63 million | Q3 2025: -$27.01 million.
- Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Operating Income Loss has declined by 3,810.9%.
- Historical annual values: Fiscal year 2025: -$115.88 million | Fiscal year 2024: -$92.11 million | Fiscal year 2023: -$107.74 million | Fiscal year 2022: -$157.62 million | Fiscal year 2021: -$118.75 million | Fiscal year 2020: -$13.99 million | Fiscal year 2019: $13.01 million | Fiscal year 2018: $10.04 million | Fiscal year 2017: $2.90 million | Fiscal year 2016: $2.16 million | Fiscal year 2015: -$5.64 million | Fiscal year 2014: $2.22 million | Fiscal year 2013: $3.17 million | Fiscal year 2012: $1.21 million | Fiscal year 2011: -$409.0 thousand | Fiscal year 2010: -$2.96 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: